0001415889-21-000903.txt : 20210223
0001415889-21-000903.hdr.sgml : 20210223
20210223191818
ACCESSION NUMBER: 0001415889-21-000903
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210219
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wellisch Alejandro D
CENTRAL INDEX KEY: 0001717526
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 21667772
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02232021_040255.xml
X0306
4
2021-02-19
0000001800
ABBOTT LABORATORIES
ABT
0001717526
Wellisch Alejandro D
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
SENIOR VICE PRESIDENT
Option (right to buy)
124.04
2021-02-19
4
A
0
39994
0
A
2022-02-19
2031-02-18
Common Shares
39994
39994
D
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,331 on February 19, 2022, 13,331 on February 19, 2023, and 13,332 on February 19, 2024.
/s/ Alejandro D. Wellisch by Jessica H. Paik, Attorney-in-Fact
2021-02-23